Fidson Healthcare Plc (NGX:FIDSON)

Nigeria flag Nigeria · Delayed Price · Currency is NGN
98.50
0.00 (0.00%)
At close: Apr 16, 2026
Market Cap236.40B +445.0%
Revenue (ttm)119.06B +41.4%
Net Income9.88B +61.1%
EPS4.12 +54.1%
Shares Out2.40B
PE Ratio23.92
Forward PE14.46
Dividend1.50 (1.52%)
Ex-Dividend DateApr 15, 2026
Volume507,111
Average Volume739,580
Openn/a
Previous Close98.50
Day's Rangen/a
52-Week Range18.60 - 105.35
Beta0.72
RSI55.87
Earnings DateMar 26, 2026

About Fidson Healthcare

Fidson Healthcare Plc manufactures and distributes pharmaceutical products in Nigeria. The company operates in three segments: Over-the-Counter, Ethical Products, and Consumer Healthcare Product. It offers drugs, infusions, and injectables. The company also provides products for anti infective and anti malaria, central nervous system, and cough and cold, gastrointestinal medicines; supplements; topical/dermatological medicines; vitamins and minerals; and ophthalmic solutions. Fidson Healthcare Plc was incorporated in 1995 and is headquartered i... [Read more]

Industry Pharmaceutical Preparations
Founded 1995
Employees 674
Stock Exchange Nigerian Stock Exchange
Ticker Symbol FIDSON
Full Company Profile

Financial Performance

In 2025, Fidson Healthcare's revenue was 119.06 billion, an increase of 41.42% compared to the previous year's 84.19 billion. Earnings were 9.31 billion, an increase of 61.05%.

Financial Statements